Seminar Schedule
2008
Dec 17: Yves Pommier, MD Ph D, Laboratory of Molecular Pharmacology, National Cancer Institute
10:30 AM, TBA
Topic: TBA
Nov 19: David Newman, D Phil, Natural Products Branch, National Cancer Institute
10:30 AM, TBA
Topic: Wanderings with Nature: Mother Nature and Natural Products
Oct 15: Pradipsinh Rathod Ph D, Department of Chemistry, University of Washington
10:30 AM, TBA
Topic: New Antimetabolites Against Malaria
Sep 17: Bradley Smith Ph D, Department of Chemistry and Biochemistry, University of Notre Dame
10:30 AM, TBA
Topic: The Promise and Practice of Molecular Imaging in Drug Discovery
May 28: John Blanchard, Ph D, Department of Biochemistry, Albert Einstein College of Medicine
10:30 AM, in 5-125 Moos Tower
Topic: Tubercolosis: One Big Problem; Two Little Stories
May 21: Matthew Brenner, MD, Department of Medicine - Pulmonary and Critical Care, University of California - Irvine
10:30 AM, in 5-125 Moos Tower
Topic: Diffuse Optical Spectroscopy Assessment of Cyanide Poisoning and Treatment in an Animal Mode
May 7: Nikunj Somia, PhD, Department of Genetics, Cell Biology and Development, University of Minnesota 10:30 AM, in 2-580 Moos Tower
Topic: Gene Discovery Using Retroviral Vectors: From Cancer to HIV
Apr 16: Mark Walter, PhD, Department of Microbiology and Structural Biology, University of Alabama 10:30 AM, in 2-650 Moos Tower
Topic: Structural Analysis of Cytokine Receptor Interactions to Aid Drug Discovery
Mar 19: Suzanne Walker, Ph D, Department of Chemistry and Biochemistry, Harvard 10:30 AM, in 5-125 Moos Tower
Topic: Glycosyltransferase Inhibitros
2007
Dec 19: Chengguo Xing, PhD, Department of Medicinal Chemistry, University of Minnesota 10:30 AM, in 1-450 Moos Tower
Topic: Studies of HA 14-1 - Can we selectively target ER-specific Bcl-2 protein?
Nov 14: Gerry Boss, MD, Department of Medicine, UCSD 10:30 AM, in 2-530 Moos Tower
Topic: Of Fire, Bugs, and Terrorists: The Many Faces of Cyanide
Oct 17: Carole Bewley, PhD, Laboratory of Bioorganic Chemistry, NIH 10:45 AM, in 2-530 Moos Tower
Topic: Structural studies of HIV-1 coreceptors and inhibitors
Sep 19: Vern L. Schramm, PhD, Department of Biochemistry, Albert Einstein College of Medicine, Yeshiva University 10:30 AM, in 2-530 Moos Tower
Topic: Enzymatic Transition States and Inhibitor Design
Apr 18: Nouri Neamati, PhD, Department of Pharmacology and Pharmaceutical Sciences, University of Southern California 10:30 AM, in 5-125 Moos Tower
Topic: Design and discovery of second-generation HIV-1 integrase inhibitors
Mar 21: Anthony Pegg, PhD, Department of Cellular and Molecular Physiology, Penn State Milton S. Hershey Medical Center 3:30 PM, in 1-450G Moos Tower
Topic: Inactivation of DNA Repair Alkyltransferase by Pseudosubstrates
Feb 21: Allen Reitz, PhD, RW Johnson PRI
3:30 PM, in 5-125 Moos Tower
Topic: BACE Inhibitors for the Treatment of Alzheimer's Disease
1:30 PM, in 2-520 WDH
Topic: Strategies for target selection and lead optimization to improve tuberculosis chemotherapy.
2006
4:00 PM, in 2-520 WDH
Topic: How to turn the sweet tooth of viruses into their Achilles' heel by utilizing antiviral lectins.
4:00 PM, in 2-520 WDH
Topic: Silence as Therapy: RNA interference using chemically modified siRNAs
1:30 PM, in 4-180 WDH
Topic: Emergence of Staphylococcus aureus as a Clinical Scourge
1:30 PM, in 4-180 WDH
Topic: Acylnitroso Cycloaddition Chemistry: Applications to the Design, Syntheses and Studies of Bioactive Compounds
April 19: Steven Ealick, PhD, Department of Chemistry and Chemical Biology, Cornell University 10:30 AM, in 4-180 WDH
Topic: Structural Evidence for Evolution of the Purine Biosynthetic Pathway
11:30 AM in 2-520 Moos Tower.
Topic: The Discovery and Development of Blood-Brain Barrier (BBB) Penetrating Anthracyclines for the Treatment of Brain Tumors.
1:30 PM in 2-520 Moos Tower.
Topic: Transferred Organelles and Pathways as Drug Targets in Protozoan Parasites.
1:30 PM in 4-180 WDH.
Topic: Patent Strategies and Techniques - A Guide for University Professionals.
Jan 18: Shana Sturla, PhD, Department of Medicinal Chemistry, University of Minnesota 1:30 PM in 4-180 Weaver-Densford Hall
Topic: Acylfulvenes: Reductive Bioactivation and Antitumor Actitivy.
2005
1:30 PM in 2-520 Moos Tower
Topic: Design of Glycogen Phosphorylase Inhibitors: An Example of Turn-Key Preclinical Drug Discovery.
9:30 AM in 4-180 Weaver-Densford Hall
Topic: Flavivirus Replication and Antiviral Drug Discovery.
10:30 AM in 7-193/195 WDH
Topic: Nucleotide Chemistry & Biotechnology Applications.
1:30 PM in 7-193/195 WDH
Topic: Protecting Your Interests: Patent Law and Research.
10:30 AM in 2-580 Moos Tower
Topic: IMP Dehydrogenase and the Dynamics of Drug Selectivity.
9:15 AM in 7-193/195 WDH
Topic: Medicinal Chemistry of RNA-based Therapeutics.
2004
10:15 AM in 7-193/195 WDH
Topic: Mycolic acids, Menaquinone and Mycobactin: Tuberculosis Drug Discovery Beyond the Magic Mountain.
Nov. 15: Dr. Dan Cook, Carlsbad Pharmaceuticals
11:00 AM in 7-193/195 WDH
Topic: Novel Anti-HIV Agents: Nucleoside Triphosphate Mimics (N3PMs) and their Prodrugs (N3PM-PDs).
|
